title: Hepatitis B and renal transplantation.
abstract: Renal transplantation in HBsAg+ chronic carriers has a relative low risk of progressive liver disease, with mortality associated with liver disease at 7%. In contrast, HBsAg+ recipients who acquired their disease in the early posttransplant period had a mortality of 60%. HBeAg-positive patients who remain persistently positive are a subgroup with a poor prognosis and should not be offered a renal transplant.
authors.affiliation: Fairfield Infectious Diseases Hospital, Melbourne, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Scott
authors.forename: A
authors.initials: A
authors.lastname: Mijch
authors.forename: C R
authors.initials: CR
authors.lastname: Lucas
authors.forename: V
authors.initials: V
authors.lastname: Marshall
authors.forename: N
authors.initials: N
authors.lastname: Thomson
authors.forename: R
authors.initials: R
authors.lastname: Atkins
mesh_terms: D000328:Adult; D005500:Follow-Up Studies; D006085:Graft Survival; D006509:Hepatitis B / Q000150:complications*; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006513:Hepatitis B e Antigens / Q000032:analysis; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D011379:Prognosis; D012189:Retrospective Studies
chemical_list: D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens